ISO 10993-1:2025

Biological evaluation process for medical devices according to ISO 10993-1 within a risk management framework across the device life cycle

Classification of substance based medical devices under Rule 21 of MDR depends on absorption, local dispersion and route of administration.

Substance based medical devices are classified according to Rule 21 of MDR 2017/745 based on their intended use, route of administration and level of absorption or local dispersion in the human body. A structured evaluation supported by toxicological and regulatory expertise is essential to determine the correct classification and ensure compliance.

Both comments and trackbacks are currently closed.